Information Provided By:
Fly News Breaks for September 13, 2017
Sep 13, 2017 | 08:12 EDT
Baird analyst Jonathan Kemp said he remains comfortable that near-term estimates for Under Armour have been appropriately set, although skepticism about Q4 will likely remain in the short-term. He remains optimistic that structural changes to the business model can yield improving results into 2018 and beyond. Kemp reiterated his Outperform rating based on a 6-12 month view and maintained his $25 price target on Under Armour shares.
News For UAA;UA From the Last 2 Days
Nov 22, 2017 | 07:13 EDT
After The Wall Street Journal reported that Peter Ruppe, SVP of Footwear, will be leaving Under Armour, Stifel analyst Jim Duffy noted that this follows a number of other senior executive departures in the past twelve months, which he sees suggesting "troubling" instability and lack of clear direction. However, the recent addition of Patrik Frisk as President and COO holds promise to introduce leadership continuity, said Duffy, who keeps a Hold rating and $12 price target on Under Armour shares.
Nov 21, 2017 | 16:18 EDT
Stocks opened sharply higher and proceeded to tack on gains in the early hours of trading. In the process, the Dow, S&P, Nasdaq, and Russell indices hit new all-time highs. Once the averages found a level, they proceeded to move in a very narrow range into the close. Oil prices also moved higher and closed with a gain of about 1%. ECONOMIC EVENTS: In the U.S., existing home sales grew 2.0% to a 5.48M unit rate in October, beating estimates. COMPANY NEWS: As widely anticipated, the U.S. Department of Justice confirmed last night that it is suing to block AT&T (T) and Time Warner's (TWX) merger deal. In response, AT&T's General Counsel said the lawsuit is "a radical and inexplicable departure from decades of antitrust precedent" and the company is "confident that the Court will reject the Government's claims" and permit the merger. Separately, another U.S. regulator made its own proposal that could benefit AT&T, as FCC Chairman Ajit Pai formally proposed to end net neutrality rules put in place by the Obama administration... The U.S. Food and Drug Administration approved Juluca from ViiV Healthcare, a joint venture between GlaxoSmithKline (GSK) and Pfizer (PFE). According to the FDA, Juluca is the first complete treatment regimen containing only two drugs to treat certain adults with human immunodeficiency virus type 1 instead of three or more drugs included in standard HIV treatment... Meanwhile, Under Armour (UAA) shares slipped over 4% as the Wall Street Journal reported that Peter Ruppe, the company's senior vice president of footwear, is leaving the company as it struggles with slowing sales. A spokeswoman told the Journal that Ruppe will be succeeded by Ryan Drew, who previously served as general manager of the basketball division. MAJOR MOVERS: Among the notable gainers following their earnings reports were Jacobs Engineering (JEC), which rose 9%. Also higher was OraSure Technologies (OSUR), which jumped 18.5% after the company announced that its subsidiary DNAG Genotek has entered into a $143M agreement for the supply of its Oragene Dx devides to an undisclosed customer. Among the noteworthy losers following their earnings reports were Campbell Soup (CPB), which dropped 8%, DSW (DSW), which fell 13%, and Signet Jewelers (SIG), which plunged 30%. Also lower was Cytokinetics (CYTK), which declined over 25% after the company announced that the Phase 3 tirasemtiv study in amyotrophic lateral sclerosis patients missed on both primary and secondary endpoints. INDEXES: The Dow rose 160.50, or 0.69%, to 23,590.83, the Nasdaq gained 71.76, or 1.06%, to 6,862.48, and the S&P 500 advanced 16.89, or 0.65%, to 2,599.03.
Nov 21, 2017 | 15:03 EDT
Peter Ruppe, the senior VP of footwear for Under Armour, is leaving the company as it struggles with slowing sales, reported The Wall Street Journal. A spokeswoman confirmed Ruppe is leaving and will be succeeded by Ryan Drew, who previously served as general manager of the basketball division. Reference Link
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.